Surgery Doctors in Virginia Beach, VA Accepting Medicare

46 Surgery doctors found. Showing 41 - 46

Alexander Marino Sailon, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 2829 Shore Dr Ste 200, Virginia Beach, VA 23451 Phone: 757-734-1000    Fax: 757-735-1001

Dr. John P Clarke, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1297 Holly Point Rd, Virginia Beach, VA 23454 Phone: 757-481-4879    Fax: 757-481-4927

Juni A. Femi-pearse, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 5484 Memorial Dr, Virginia Beach, VA 23455 Phone: 505-702-5404    Fax: 757-228-7323

Dr. Leanelle Goldstein, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1080 First Colonial Rd Ste 200, Virginia Beach, VA 23454 Phone: 757-395-6070    Fax: 757-395-6381

Todd W Gensler, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 397 Little Neck Rd Ste 120, Virginia Beach, VA 23452 Phone: 757-395-1600    Fax: 757-961-9359

Nicholas Lee Bandy, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2075 Glenn Mitchell Dr Ste 512, Virginia Beach, VA 23456 Phone: 757-507-8850

News Archive

FDA grants Orphan Drug Designation for Accentia's Revimmune to prevent GVHD

Accentia Biopharmaceuticals, Inc. and its majority-owned subsidiary, Biovest International, Inc., today jointly announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to Revimmune, the Company's proprietary system-of-care based on high-dose administration of Cytoxan, for the prevention of graft-versus-host disease (GVHD) following bone marrow transplant.

Ardea Biosciences reports lower net loss of $10.1M for first-quarter 2010

Ardea Biosciences, Inc. a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments and financial results for the first quarter ended March 31, 2010.

Tumor count in the breast an important consideration for providing radiation therapy

Not all women diagnosed with operable breast cancer present with a single tumor; some have multifocal disease appear in the breast, which means multiple tumors found in the same breast quadrant, while others have multicentric disease, where multiple tumors are found in separate breast quadrants. Multifocal or multicentric disease is not a standard indication to receive radiation after mastectomy. For patients who undergo lumpectomy, radiation dose and extent is not altered based on multifocal or multicentric disease compared to patients presenting with a single tumor.

Cardio3 BioSciences announces first patient enrollment in NKG2D CAR T-Cell Phase I clinical trial

Cardio3 BioSciences (C3BS), a leader in engineered cell-therapy treatments with clinical programs initially targeting indications in cardiovascular disease and oncology, today announced the enrollment of the first patient in a Phase I clinical trial evaluating the Company's lead CAR T-Cell therapy, NKG2D CAR T-Cell, in blood cancer patients with acute myeloid leukemia (AML) or multiple myeloma (MM).

Novel saliva test could fast track heart attack diagnosis

A saliva test could fast track heart attack diagnosis, according to preliminary research presented today at ESC Congress 2020.

Read more Medical News

› Verified 5 days ago

• 1
• 2
• 3(current)